Coronary stent NOVELTY

cobalt-chromiumdrug eluting

NOVELTY Everolimus Eluting Coronary Stent System is the latest in the second generation of drug eluting stents, an ultimate combination of three outstanding elements: a clinically proven drug - Everolimus, a modified Cobalt Chromium stent platform, and an excellent bioabsorbable drug carrier. NOVELTY takes the ideal definition of Safety - Efficiency - Deliverability for Percutaneous Coronary Intervention (PCI) to a higher level, convinces with its trusted technology and largest size portfolio available, provides high end performance with less metallic coverage but reliable outcomes, and offers an optimal solution for improving luminal diameter and reducing in-stent restenosis when treating coronary artery lesions. Features X-ray and MRI compatible stent material and excellent radial strength Perfect flexibility due to open design of shaped interlinks per segments Optimized cell sizes and shape to minimize stent induced arterial injuries Stent platform controls effectively the drug release kinetics. Very smooth proximal shaft and low tip profile to access the most challenging and tortuous lesions. Validated pleating and folding methodology for different balloon diameters combines with advanced stent crimping technology ensure the decreased crossing profile resulting in an easy side branch access.